• Mashup Score: 0
    WHO Recommends COVID-19 Treatments Paxlovid and Remdesivir - 2 year(s) ago

    The World Health Organization (WHO) has strongly recommended nirmatrelvir and ritonavir (Paxlovid), as well as remdesivir, for COVID-19 treatment. WHO emphasized that these medicines should be made accessible to low- and middle-income countries.

    Source: Contagion Live
    Categories: Infectious Disease, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of Contagion_Live
      Contagion_Live

      #ICYMI: @WHO strongly recommended nirmatrelvir and ritonavir (#Paxlovid)for #COVID19 treatment, while pressuring @pfizer to make the medicine accessible to low- and middle-income countries. #WHO also reversed their prior recommendation against #remdesivir. https://t.co/KgFE25Oy4M

  • Mashup Score: 3
    WHO Recommends COVID-19 Treatments Paxlovid and Remdesivir - 2 year(s) ago

    The World Health Organization (WHO) has strongly recommended nirmatrelvir and ritonavir (Paxlovid), as well as remdesivir, for COVID-19 treatment. WHO emphasized that these medicines should be made accessible to low- and middle-income countries.

    Source: Contagion Live
    Categories: Infectious Disease, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of Contagion_Live
      Contagion_Live

      #Breaking: Today, @WHO strongly recommended nirmatrelvir and ritonavir (#Paxlovid), as well as #remdesivir, for #COVID19 treatment. WHO emphasized these medicines should be made accessible to low- and middle-income countries. https://t.co/RUVBgFhM29

  • Mashup Score: 4
    A living WHO guideline on drugs for covid-19 - 2 year(s) ago

    Updates This is the tenth version (ninth update) of the living guideline, replacing earlier versions, available as data supplements. New recommendations will be published as updates to this guideline. Clinical question What is the role of drugs in the treatment of patients with covid-19? Context The evidence base for therapeutics for covid-19 is evolving with numerous recently completed…

    Source: The BMJ
    Categories: Infectious Disease, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of KrutikaKuppalli
      KrutikaKuppalli

      In our latest @WHO #COVID19 Therapeutics guidelines We strongly recommend #Paxlovid & conditionally recommend. #Remdesivir in patients at ⬆️ risk for hospitalization @bmj_latest: https://t.co/BWWCTwvAtN @WHO: https://t.co/I71YdmXF8S @theMAGICapp: https://t.co/RWtyVaL7r5 https://t.co/W1ayoaqc65

  • Mashup Score: 2
    Drug dosing in hospitalized obese patients with COVID-19 - Critical Care - 2 year(s) ago

    Obesity is highly prevalent in hospitalized patients admitted with COVID-19. Evidence based guidelines are available for COVID-19-related therapies but dosing information specific to patients with obesity is lacking. Failure to account for the pharmacokinetic alterations that exist in this population can lead to underdosing, and treatment failure, or overdosing, resulting in an adverse effect….

    Source: BioMed Central
    Categories: Critical Care, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of Crit_Care
      Crit_Care

      #CritCare #OpenAccess #COVID_19: guidance for making treatment #dosing decisions in obese patients https://t.co/7lgHbg072b @jlvincen @ISICEM #FOAMed #FOAMcc #BMC #ICU #Dexamethasone #Baricitinib #Tofacitinib #Tocilizumab #Sarilumab #Remdesivir https://t.co/VM5VgQOcCY

  • Mashup Score: 1
    Wolters Kluwer Health - 2 year(s) ago

    JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable…

    Source: lww.com
    Categories: Emergency Medicine, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of EMNews
      EMNews

      Most #COVID19 #ED patients are #unvaccinated, but the #therapeutics being used have varying efficacy, say Mattie Erby, MD, Massud Atta, MD, & Ali Kamran, MD. #remdesivir #dexamethasone #REGEN-COV #baricitinib #hydroxychloroquine #azithromycin #ivermectin https://t.co/arLcbr9Ggj https://t.co/oKhKERl5Sb

  • Mashup Score: 9
    COVID-19 Guideline, Part 1: Treatment and Management - 2 year(s) ago

    IDSA has developed living, frequently updated evidence-based guidelines to support patients, clinicians and other health-care professionals in their decisions about treatment and management of patients with COVID-19 infection. Summarized here are the recommendations with comments related to the clinical practice guideline for the treatment and management of COVID-19.

    Source: www.idsociety.org
    Categories: Infectious Disease, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of IDSAInfo
      IDSAInfo

      IDSA has revised its recommendation on use of #remdesivir in patients (ambulatory or hospitalized) w/ mild-to-moderate COVID-at high risk for progression to severe disease: https://t.co/4HJlv4I55I See below ⬇️ #COVID19Guidelines @adarsh_bhimraj @RMKGandhi @JGPharmD @ShohamTxID https://t.co/Xrtq5bjObJ

Load More